Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Expression of Melanoma Antigen Genes A11 and A12 in Non-Small Cell Lung Cancer

Folia Medica Indonesiana · Vol. 59 No. 4 (2023) · hlm. 363–369

DOI
10.20473/fmi.v59i4.50477
ISSN
2355-8393, 2599-056X
Terbit
2023-12-10
Penerbit
Airlangga University
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc-sa/4.0/

Abstrak

Highlights:1. In this study, new primers designed using the semi-nested polymerase chain reaction (PCR) method were utilized to identify MAGE-A11 and MAGE-A12 expressions in specimens collected from core biopsy, forcep biopsy, and bronchoalveolar lavage.2. The histopathological analysis revealed positive expressions of MAGE-A11 and MAGE-A12 in specimens diagnosed with non-small cell lung cancer (NSCLC) as well as in specimens with no malignant cells. AbstractThe melanoma antigen gene (MAGE) belongs to the group of cancer testis antigens that are exclusively expressed in germ cells but may be re-expressed in cancer cells. The highly expressed MAGE-A subfamily in lung cancer may potentially be a diagnostic and prognostic biomarker. This study aimed to identify MAGE-A11 and MAGE-A12 expressions in lung tumors obtained from core biopsy, forceps biopsy, and bronchoalveolar lavage specimens. A cross-sectional observational study was conducted on 90 patients clinically diagnosed with lung tumors. These patients received core biopsy, forceps biopsy, and bronchoalveolar lavage interventions after ethical approval was obtained. The complementary deoxyribonucleic acid (cDNA) quality was assessed by the polymerase chain reaction (PCR) of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The assessment was performed to ascertain if all specimens exhibited positive PCR amplification of the GAPDH gene. MAGE-A11 and MAGE-A12 were identified through a semi-nested reverse transcription PCR. The positive results were detected by measuring the PCR products, with MAGE-A11 and MAGE-A12 measuring at base pairs (bp) of 858 and 496 in the first and second rounds, respectively. The expressions of MAGE-A11 and MAGE-A12 were observed in 3 (3.33%) and 40 (44.44%) out of 90 specimens, respectively. The prevalence rate of non-small cell lung cancer (NSCLC) was 31.11% (28/90). Among these cases, 3.57% (1/28) showed the expression of MAGE-A11, while 32.14% (9/28) exhibited the expression of MAGE-A12. Sixty-two (68.89%) out of 90 patients were diagnosed with no tumor cell malignancy. Out of 62 cases, 2 (3.23%) exhibited the expression of MAGE-A11, while 31 (50%) demonstrated the expression of MAGE-A12. MAGE-A11 and MAGE-A12 were detected in NSCLC and in certain specimens with a pathological diagnosis that indicated the absence of malignant cells. In conclusion, MAGE A11 and MAGE A12 have potential markers that can improve the pathological diagnosis of lung cancer. Further investigation is necessary to explore the expression of MAGE-A in correlation with lung cancer progression.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 96 tautan kepenulisan bersama · 14 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Tanjungpura University
  • Sumatera Institute of Technology
  • Universitas Noor Huda Mustofa
  • Rumah Sakit Dokter Soetomo
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Suhartono Taat PutraUniversitas Airlangga4
Nila KurniasariUniversitas Airlangga4
Anny Setijo RahajuUniversitas Airlangga4
Sjahjenny MustokoweniUniversitas Airlangga4
Sri Agus SudjarwoUniversitas Airlangga3
Aucky HintingUniversitas Airlangga3
Etty Hary KusumastutiUniversitas Airlangga2
Ni Nyoman Tri PuspaningsihUniversitas Airlangga2
Sunaryo HardjowijotoUniversitas Airlangga2
JH LunardiAfiliasi tidak diketahui2
Hamdani LunardhiUniversitas Airlangga2
Doddy Moesbadianto SoebadiUniversitas Airlangga2
Budi HarjantoRumah Sakit Dokter Soetomo2
Dwi MurtiastutikUniversitas Airlangga2
Afria AristaUniversitas Airlangga2
Trisniartami SetyaningrumUniversitas Airlangga2
Rahmi AliaAfiliasi tidak diketahui2
Faisal AmirSumatera Institute of Technology1
M. HasinuddinUniversitas Noor Huda Mustofa1
Alis Nur DianaUniversitas Airlangga1
Sri PurwaningsihUniversitas Airlangga1
Reryd Arindany WiryawanAfiliasi tidak diketahui1
Maria Paulina Budyandini Dyah PramestiUniversitas Airlangga1
Hamdani LunardhiAfiliasi tidak diketahui1
Evy WulandariUniversitas Airlangga1
Soegeng Soekamto MartoprawiroAfiliasi tidak diketahui1
Rahmawati RaharjoAfiliasi tidak diketahui1
Rizki Eko PrasetyoUniversitas Airlangga1
Arifa MustikaUniversitas Airlangga1
Sandra Dewi SitaresmiUniversitas Airlangga1
Yugi Hari Chandra PurnamaUniversitas Airlangga1
Soetjipto SoetjiptoUniversitas Airlangga1
Troef SoemarnoAfiliasi tidak diketahui1
Ninik DarsiniUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Expression of Melanoma Antigen Genes A11 and A12 in Non-Small Cell Lung Cancer</dc:title><dc:creator>Gondo Mastutik</dc:creator><dc:creator>Alphania Rahniayu</dc:creator><dc:creator>Isnin Anang Marhana</dc:creator><dc:creator>Mochamad Amin</dc:creator><dc:creator>Heru Fajar Trianto</dc:creator><dc:creator>Reny I’tishom</dc:creator><dc:subject>non-small cell lung cancer</dc:subject><dc:subject>cancer-testis antigens</dc:subject><dc:subject>gene expression</dc:subject><dc:subject>bronchoalveolar lavage</dc:subject><dc:subject>core needle biopsy</dc:subject><dc:subject>forceps biopsy</dc:subject><dc:subject>tumor markers</dc:subject><dc:subject>semi-nested RT-PCR</dc:subject><dc:subject>lung cancer diagnosis</dc:subject><dc:subject>prognosis</dc:subject><dc:description xml:lang="en">Highlights:1. In this study, new primers designed using the semi-nested polymerase chain reaction (PCR) method were utilized to identify MAGE-A11 and MAGE-A12 expressions in specimens collected from core biopsy, forcep biopsy, and bronchoalveolar lavage.2. The histopathological analysis revealed positive expressions of MAGE-A11 and MAGE-A12 in specimens diagnosed with non-small cell lung cancer (NSCLC) as well as in specimens with no malignant cells. AbstractThe melanoma antigen gene (MAGE) belongs to the group of cancer testis antigens that are exclusively expressed in germ cells but may be re-expressed in cancer cells. The highly expressed MAGE-A subfamily in lung cancer may potentially be a diagnostic and prognostic biomarker. This study aimed to identify MAGE-A11 and MAGE-A12 expressions in lung tumors obtained from core biopsy, forceps biopsy, and bronchoalveolar lavage specimens. A cross-sectional observational study was conducted on 90 patients clinically diagnosed with lung tumors. These patients received core biopsy, forceps biopsy, and bronchoalveolar lavage interventions after ethical approval was obtained. The complementary deoxyribonucleic acid (cDNA) quality was assessed by the polymerase chain reaction (PCR) of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The assessment was performed to ascertain if all specimens exhibited positive PCR amplification of the GAPDH gene. MAGE-A11 and MAGE-A12 were identified through a semi-nested reverse transcription PCR. The positive results were detected by measuring the PCR products, with MAGE-A11 and MAGE-A12 measuring at base pairs (bp) of 858 and 496 in the first and second rounds, respectively. The expressions of MAGE-A11 and MAGE-A12 were observed in 3 (3.33%) and 40 (44.44%) out of 90 specimens, respectively. The prevalence rate of non-small cell lung cancer (NSCLC) was 31.11% (28/90). Among these cases, 3.57% (1/28) showed the expression of MAGE-A11, while 32.14% (9/28) exhibited the expression of MAGE-A12. Sixty-two (68.89%) out of 90 patients were diagnosed with no tumor cell malignancy. Out of 62 cases, 2 (3.23%) exhibited the expression of MAGE-A11, while 31 (50%) demonstrated the expression of MAGE-A12. MAGE-A11 and MAGE-A12 were detected in NSCLC and in certain specimens with a pathological diagnosis that indicated the absence of malignant cells. In conclusion, MAGE A11 and MAGE A12 have potential markers that can improve the pathological diagnosis of lung cancer. Further investigation is necessary to explore the expression of MAGE-A in correlation with lung cancer progression.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2023-12-10</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v59i4.50477</dc:identifier><dc:identifier>10.20473/fmi.v59i4.50477</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 59 No 4 (2023); 363-369</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/50477/27342</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>